avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smad1
|
ENSMUSG00000031681.8 | SMAD family member 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Smad1 | mm10_v2_chr8_-_79399513_79399532 | 0.06 | 7.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_111691002 | 15.28 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr2_-_28563362 | 11.42 |
ENSMUST00000028161.5
|
Cel
|
carboxyl ester lipase |
chr6_-_41314700 | 7.83 |
ENSMUST00000064324.5
|
Try5
|
trypsin 5 |
chr6_+_41521782 | 7.81 |
ENSMUST00000070380.4
|
Prss2
|
protease, serine, 2 |
chr14_-_51146757 | 7.62 |
ENSMUST00000080126.2
|
Rnase1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_+_93006328 | 7.04 |
ENSMUST00000059676.4
|
Aqp12
|
aquaporin 12 |
chr19_+_58728887 | 6.41 |
ENSMUST00000048644.5
|
Pnliprp1
|
pancreatic lipase related protein 1 |
chr19_+_4081565 | 6.10 |
ENSMUST00000159593.1
|
Cabp2
|
calcium binding protein 2 |
chr4_+_115518264 | 6.01 |
ENSMUST00000058785.3
ENSMUST00000094886.3 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr4_-_141825997 | 5.79 |
ENSMUST00000102481.3
|
Cela2a
|
chymotrypsin-like elastase family, member 2A |
chr10_+_79886302 | 5.69 |
ENSMUST00000046091.5
|
Elane
|
elastase, neutrophil expressed |
chr6_+_41302265 | 4.92 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr7_+_24777172 | 4.81 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr19_+_4082473 | 4.71 |
ENSMUST00000159148.1
|
Cabp2
|
calcium binding protein 2 |
chr9_+_111019284 | 3.96 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr17_-_31144271 | 3.91 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr7_-_142679533 | 3.59 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr6_+_122513676 | 3.55 |
ENSMUST00000142896.1
ENSMUST00000121656.1 |
Mfap5
|
microfibrillar associated protein 5 |
chr7_-_45333754 | 3.49 |
ENSMUST00000042194.8
|
Trpm4
|
transient receptor potential cation channel, subfamily M, member 4 |
chr11_-_102107822 | 3.40 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr3_+_107230608 | 3.35 |
ENSMUST00000179399.1
|
A630076J17Rik
|
RIKEN cDNA A630076J17 gene |
chr7_-_142576492 | 3.34 |
ENSMUST00000140716.1
|
H19
|
H19 fetal liver mRNA |
chr4_+_115600975 | 3.29 |
ENSMUST00000084342.5
|
Cyp4a32
|
cytochrome P450, family 4, subfamily a, polypeptide 32 |
chr2_+_84980458 | 3.21 |
ENSMUST00000028467.5
|
Prg2
|
proteoglycan 2, bone marrow |
chr12_-_8539545 | 3.16 |
ENSMUST00000095863.3
ENSMUST00000165657.1 |
Slc7a15
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 15 |
chr4_-_137430517 | 3.01 |
ENSMUST00000102522.4
|
Cela3b
|
chymotrypsin-like elastase family, member 3B |
chr6_+_78425973 | 2.76 |
ENSMUST00000079926.5
|
Reg1
|
regenerating islet-derived 1 |
chr12_-_103958939 | 2.71 |
ENSMUST00000122229.1
|
Serpina1e
|
serine (or cysteine) peptidase inhibitor, clade A, member 1E |
chr6_+_122513583 | 2.65 |
ENSMUST00000032210.7
ENSMUST00000148517.1 |
Mfap5
|
microfibrillar associated protein 5 |
chr17_-_26199008 | 2.64 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr3_-_107239707 | 2.57 |
ENSMUST00000049852.8
|
Prok1
|
prokineticin 1 |
chr6_-_69284319 | 2.50 |
ENSMUST00000103349.1
|
Igkv4-69
|
immunoglobulin kappa variable 4-69 |
chr7_+_19411086 | 2.49 |
ENSMUST00000003643.1
|
Ckm
|
creatine kinase, muscle |
chr7_-_131322292 | 2.44 |
ENSMUST00000046611.7
|
Cuzd1
|
CUB and zona pellucida-like domains 1 |
chr17_-_28560704 | 2.41 |
ENSMUST00000114785.1
ENSMUST00000025062.3 |
Clps
|
colipase, pancreatic |
chr6_+_122513643 | 2.39 |
ENSMUST00000118626.1
|
Mfap5
|
microfibrillar associated protein 5 |
chr1_+_134182404 | 2.39 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chr12_+_109452833 | 2.38 |
ENSMUST00000056110.8
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr13_+_112288451 | 2.37 |
ENSMUST00000022275.6
ENSMUST00000056047.7 ENSMUST00000165593.1 |
Ankrd55
|
ankyrin repeat domain 55 |
chr4_-_119189949 | 2.36 |
ENSMUST00000124626.1
|
Ermap
|
erythroblast membrane-associated protein |
chr18_-_43737186 | 2.36 |
ENSMUST00000025381.2
|
Spink3
|
serine peptidase inhibitor, Kazal type 3 |
chr13_-_120027011 | 2.15 |
ENSMUST00000177659.1
|
Gm21370
|
predicted gene, 21370 |
chr12_-_114416895 | 2.14 |
ENSMUST00000179796.1
|
Ighv6-5
|
immunoglobulin heavy variable V6-5 |
chr2_-_28084877 | 2.13 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
chr4_-_4138817 | 2.12 |
ENSMUST00000133567.1
|
Penk
|
preproenkephalin |
chr10_+_75571522 | 2.12 |
ENSMUST00000143226.1
ENSMUST00000124259.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr11_+_49794157 | 2.10 |
ENSMUST00000020629.4
|
Gfpt2
|
glutamine fructose-6-phosphate transaminase 2 |
chr5_+_90490714 | 2.10 |
ENSMUST00000042755.3
|
Afp
|
alpha fetoprotein |
chr19_+_58759700 | 2.09 |
ENSMUST00000026081.3
|
Pnliprp2
|
pancreatic lipase-related protein 2 |
chr6_+_68161415 | 2.08 |
ENSMUST00000168090.1
|
Igkv1-115
|
immunoglobulin kappa variable 1-115 |
chr11_+_7197780 | 2.08 |
ENSMUST00000020704.7
|
Igfbp1
|
insulin-like growth factor binding protein 1 |
chr15_+_101293196 | 2.07 |
ENSMUST00000071328.6
|
6030408B16Rik
|
RIKEN cDNA 6030408B16 gene |
chr7_-_24760311 | 2.06 |
ENSMUST00000063956.5
|
Cd177
|
CD177 antigen |
chr12_-_113422730 | 1.99 |
ENSMUST00000177715.1
ENSMUST00000103426.1 |
Ighm
|
immunoglobulin heavy constant mu |
chr6_+_86078070 | 1.96 |
ENSMUST00000032069.5
|
Add2
|
adducin 2 (beta) |
chr8_-_122460666 | 1.94 |
ENSMUST00000006762.5
|
Snai3
|
snail homolog 3 (Drosophila) |
chr4_-_133498538 | 1.92 |
ENSMUST00000125541.1
|
Trnp1
|
TMF1-regulated nuclear protein 1 |
chr6_+_86628174 | 1.92 |
ENSMUST00000043400.6
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr1_+_65311257 | 1.92 |
ENSMUST00000027083.6
|
Pth2r
|
parathyroid hormone 2 receptor |
chr13_+_112288516 | 1.91 |
ENSMUST00000168684.1
|
Ankrd55
|
ankyrin repeat domain 55 |
chr13_-_4150628 | 1.91 |
ENSMUST00000110704.2
ENSMUST00000021635.7 |
Akr1c18
|
aldo-keto reductase family 1, member C18 |
chr10_+_127759780 | 1.90 |
ENSMUST00000128247.1
|
RP23-386P10.11
|
Protein Rdh9 |
chr10_+_75948292 | 1.88 |
ENSMUST00000000926.2
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr5_-_120795530 | 1.88 |
ENSMUST00000100785.3
|
Oas1e
|
2'-5' oligoadenylate synthetase 1E |
chr6_-_115762346 | 1.88 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr11_+_70639118 | 1.87 |
ENSMUST00000055184.6
ENSMUST00000108551.2 |
Gp1ba
|
glycoprotein 1b, alpha polypeptide |
chr7_-_25882407 | 1.86 |
ENSMUST00000163316.2
|
Gm6434
|
predicted gene 6434 |
chr17_+_28769307 | 1.85 |
ENSMUST00000004986.6
|
Mapk13
|
mitogen-activated protein kinase 13 |
chr16_-_36367623 | 1.81 |
ENSMUST00000096089.2
|
BC100530
|
cDNA sequence BC100530 |
chr9_+_110419750 | 1.81 |
ENSMUST00000035061.6
|
Ngp
|
neutrophilic granule protein |
chr8_+_94377911 | 1.80 |
ENSMUST00000159142.1
|
Gm15889
|
predicted gene 15889 |
chr6_-_69400097 | 1.80 |
ENSMUST00000177795.1
|
Igkv4-62
|
immunoglobulin kappa variable 4-62 |
chr9_-_44288535 | 1.79 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr14_-_60177482 | 1.77 |
ENSMUST00000140924.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr1_+_130865669 | 1.76 |
ENSMUST00000038829.5
|
Faim3
|
Fas apoptotic inhibitory molecule 3 |
chr7_+_24897381 | 1.75 |
ENSMUST00000003469.7
|
Cd79a
|
CD79A antigen (immunoglobulin-associated alpha) |
chr17_-_31129602 | 1.74 |
ENSMUST00000024827.4
|
Tff3
|
trefoil factor 3, intestinal |
chr4_-_149454971 | 1.71 |
ENSMUST00000030848.2
|
Rbp7
|
retinol binding protein 7, cellular |
chr11_-_6520894 | 1.71 |
ENSMUST00000003459.3
|
Myo1g
|
myosin IG |
chr2_+_84988194 | 1.70 |
ENSMUST00000028466.5
|
Prg3
|
proteoglycan 3 |
chr11_+_115887601 | 1.69 |
ENSMUST00000167507.2
|
Myo15b
|
myosin XVB |
chr6_+_83743010 | 1.69 |
ENSMUST00000006431.6
|
Atp6v1b1
|
ATPase, H+ transporting, lysosomal V1 subunit B1 |
chr16_+_48872608 | 1.67 |
ENSMUST00000065666.4
|
Retnlg
|
resistin like gamma |
chr8_+_31091593 | 1.65 |
ENSMUST00000161713.1
|
Dusp26
|
dual specificity phosphatase 26 (putative) |
chr8_+_109990430 | 1.65 |
ENSMUST00000001720.7
ENSMUST00000143741.1 |
Tat
|
tyrosine aminotransferase |
chr17_+_25298389 | 1.65 |
ENSMUST00000037453.2
|
Prss34
|
protease, serine, 34 |
chr14_-_60086832 | 1.61 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr1_-_170927567 | 1.60 |
ENSMUST00000046322.7
ENSMUST00000159171.1 |
Fcrla
|
Fc receptor-like A |
chr2_-_28621932 | 1.59 |
ENSMUST00000028156.7
ENSMUST00000164290.1 |
Gfi1b
|
growth factor independent 1B |
chr2_+_25289899 | 1.59 |
ENSMUST00000028337.6
|
Lrrc26
|
leucine rich repeat containing 26 |
chr5_+_127632238 | 1.59 |
ENSMUST00000118139.1
|
Glt1d1
|
glycosyltransferase 1 domain containing 1 |
chr8_-_71723308 | 1.58 |
ENSMUST00000125092.1
|
Fcho1
|
FCH domain only 1 |
chr2_+_127336152 | 1.57 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr10_+_127849917 | 1.54 |
ENSMUST00000077530.2
|
Rdh19
|
retinol dehydrogenase 19 |
chr6_-_78378851 | 1.52 |
ENSMUST00000089667.1
ENSMUST00000167492.1 |
Reg3d
|
regenerating islet-derived 3 delta |
chr1_+_88211956 | 1.49 |
ENSMUST00000073049.6
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr15_-_100687908 | 1.49 |
ENSMUST00000023775.7
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr19_-_3414464 | 1.49 |
ENSMUST00000025842.6
|
Gal
|
galanin |
chr17_+_29135056 | 1.48 |
ENSMUST00000087942.4
|
Rab44
|
RAB44, member RAS oncogene family |
chr13_-_113100971 | 1.48 |
ENSMUST00000023897.5
|
Gzma
|
granzyme A |
chr14_+_66140919 | 1.47 |
ENSMUST00000022620.9
|
Chrna2
|
cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal) |
chr9_+_98490522 | 1.47 |
ENSMUST00000035029.2
|
Rbp2
|
retinol binding protein 2, cellular |
chr8_+_75109528 | 1.47 |
ENSMUST00000164309.1
|
Mcm5
|
minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) |
chr4_-_32602760 | 1.44 |
ENSMUST00000056517.2
|
Gja10
|
gap junction protein, alpha 10 |
chr12_-_103989917 | 1.44 |
ENSMUST00000151709.2
ENSMUST00000176246.1 ENSMUST00000074693.7 |
Serpina11
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 |
chr6_-_136922169 | 1.44 |
ENSMUST00000032343.6
|
Erp27
|
endoplasmic reticulum protein 27 |
chr12_+_104406704 | 1.44 |
ENSMUST00000021506.5
|
Serpina3n
|
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
chr4_-_96664112 | 1.41 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr17_+_84683131 | 1.38 |
ENSMUST00000171915.1
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr15_-_102189032 | 1.38 |
ENSMUST00000023805.1
|
Csad
|
cysteine sulfinic acid decarboxylase |
chr7_-_4397705 | 1.38 |
ENSMUST00000108590.2
|
Gp6
|
glycoprotein 6 (platelet) |
chr19_+_54045182 | 1.38 |
ENSMUST00000036700.5
|
Adra2a
|
adrenergic receptor, alpha 2a |
chr12_+_24831583 | 1.37 |
ENSMUST00000110942.3
ENSMUST00000078902.6 |
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr1_-_170927540 | 1.36 |
ENSMUST00000162136.1
ENSMUST00000162887.1 |
Fcrla
|
Fc receptor-like A |
chr2_-_129371131 | 1.36 |
ENSMUST00000028881.7
|
Il1b
|
interleukin 1 beta |
chr4_+_115563649 | 1.35 |
ENSMUST00000141033.1
ENSMUST00000030486.8 ENSMUST00000126645.1 ENSMUST00000030480.3 |
Cyp4a31
|
cytochrome P450, family 4, subfamily a, polypeptide 31 |
chrX_+_135993820 | 1.35 |
ENSMUST00000058119.7
|
Arxes2
|
adipocyte-related X-chromosome expressed sequence 2 |
chr5_+_33995984 | 1.34 |
ENSMUST00000056355.8
|
Nat8l
|
N-acetyltransferase 8-like |
chrX_-_7967817 | 1.33 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr17_-_7352696 | 1.32 |
ENSMUST00000115747.1
|
Ttll2
|
tubulin tyrosine ligase-like family, member 2 |
chr12_-_115964196 | 1.32 |
ENSMUST00000103550.2
|
Ighv1-83
|
immunoglobulin heavy variable 1-83 |
chr7_-_127993831 | 1.32 |
ENSMUST00000033056.3
|
Pycard
|
PYD and CARD domain containing |
chr6_-_69243445 | 1.31 |
ENSMUST00000101325.3
|
Igkv4-71
|
immunoglobulin kappa chain variable 4-71 |
chr16_+_36210403 | 1.31 |
ENSMUST00000089628.3
|
Gm5416
|
predicted gene 5416 |
chr6_+_123262107 | 1.30 |
ENSMUST00000032240.2
|
Clec4d
|
C-type lectin domain family 4, member d |
chr6_+_78380700 | 1.29 |
ENSMUST00000101272.1
|
Reg3a
|
regenerating islet-derived 3 alpha |
chr18_+_67343564 | 1.29 |
ENSMUST00000025404.8
|
Cidea
|
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
chr17_+_48232755 | 1.28 |
ENSMUST00000113251.3
ENSMUST00000048782.6 |
Trem1
|
triggering receptor expressed on myeloid cells 1 |
chr10_+_79879614 | 1.26 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr14_-_43819639 | 1.24 |
ENSMUST00000100691.3
|
Ear1
|
eosinophil-associated, ribonuclease A family, member 1 |
chr4_+_115411624 | 1.24 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr9_+_7558429 | 1.23 |
ENSMUST00000018765.2
|
Mmp8
|
matrix metallopeptidase 8 |
chr6_-_115758974 | 1.23 |
ENSMUST00000072933.6
|
Tmem40
|
transmembrane protein 40 |
chr14_+_65266701 | 1.23 |
ENSMUST00000169656.1
|
Fbxo16
|
F-box protein 16 |
chr7_-_142657466 | 1.23 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr3_-_98763053 | 1.22 |
ENSMUST00000107019.1
ENSMUST00000107018.1 ENSMUST00000125483.1 ENSMUST00000137008.1 ENSMUST00000135706.1 |
Hsd3b3
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
chr5_-_120749848 | 1.22 |
ENSMUST00000053909.6
ENSMUST00000081491.6 |
Oas2
|
2'-5' oligoadenylate synthetase 2 |
chr17_-_48451510 | 1.22 |
ENSMUST00000024794.5
|
Tspo2
|
translocator protein 2 |
chr10_-_81524225 | 1.21 |
ENSMUST00000043709.7
|
Gna15
|
guanine nucleotide binding protein, alpha 15 |
chr15_-_101491509 | 1.19 |
ENSMUST00000023718.7
|
5430421N21Rik
|
RIKEN cDNA 5430421N21 gene |
chr19_-_5394385 | 1.19 |
ENSMUST00000044527.4
|
Tsga10ip
|
testis specific 10 interacting protein |
chr1_-_132390301 | 1.19 |
ENSMUST00000132435.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr2_+_105092018 | 1.18 |
ENSMUST00000111107.1
|
Gm11060
|
predicted gene 11060 |
chr17_+_84683113 | 1.17 |
ENSMUST00000045714.8
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr13_-_120035331 | 1.17 |
ENSMUST00000178618.1
|
Gm21188
|
predicted gene, 21188 |
chr9_+_112234257 | 1.17 |
ENSMUST00000149308.3
ENSMUST00000144424.2 ENSMUST00000139552.2 |
2900079G21Rik
|
RIKEN cDNA 2900079G21 gene |
chr14_-_30923754 | 1.17 |
ENSMUST00000006697.8
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr7_+_26808880 | 1.16 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr17_-_35066170 | 1.16 |
ENSMUST00000174190.1
ENSMUST00000097337.1 |
AU023871
|
expressed sequence AU023871 |
chr11_+_98386450 | 1.16 |
ENSMUST00000041301.7
|
Pnmt
|
phenylethanolamine-N-methyltransferase |
chr17_-_32166879 | 1.16 |
ENSMUST00000087723.3
|
Notch3
|
notch 3 |
chr4_-_49383576 | 1.15 |
ENSMUST00000107698.1
|
Acnat2
|
acyl-coenzyme A amino acid N-acyltransferase 2 |
chr16_+_36277145 | 1.15 |
ENSMUST00000042097.9
|
Stfa1
|
stefin A1 |
chr7_+_25152456 | 1.15 |
ENSMUST00000098678.1
|
D930028M14Rik
|
RIKEN cDNA D930028M14 gene |
chr12_+_9574437 | 1.15 |
ENSMUST00000057021.7
|
Osr1
|
odd-skipped related 1 (Drosophila) |
chr15_-_98778150 | 1.14 |
ENSMUST00000023732.5
|
Wnt10b
|
wingless related MMTV integration site 10b |
chr10_+_75564086 | 1.14 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr7_+_13733502 | 1.14 |
ENSMUST00000086148.6
|
Sult2a2
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 2 |
chr4_+_115299046 | 1.14 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr13_-_114932035 | 1.12 |
ENSMUST00000056117.8
|
Itga2
|
integrin alpha 2 |
chr15_-_74734313 | 1.11 |
ENSMUST00000023260.3
|
Lypd2
|
Ly6/Plaur domain containing 2 |
chr11_+_115877497 | 1.10 |
ENSMUST00000144032.1
|
Myo15b
|
myosin XVB |
chr13_-_52530827 | 1.10 |
ENSMUST00000057442.6
|
Diras2
|
DIRAS family, GTP-binding RAS-like 2 |
chr3_-_107221722 | 1.09 |
ENSMUST00000029504.8
|
Cym
|
chymosin |
chr2_+_151842912 | 1.08 |
ENSMUST00000042217.3
|
Rspo4
|
R-spondin family, member 4 |
chr6_-_145450753 | 1.08 |
ENSMUST00000111706.1
|
Ifltd1
|
intermediate filament tail domain containing 1 |
chr14_-_30923547 | 1.07 |
ENSMUST00000170415.1
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr15_+_82452372 | 1.06 |
ENSMUST00000089129.5
|
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr12_+_104338372 | 1.06 |
ENSMUST00000101078.5
ENSMUST00000043058.3 |
Serpina3m
Serpina3k
|
serine (or cysteine) peptidase inhibitor, clade A, member 3M serine (or cysteine) peptidase inhibitor, clade A, member 3K |
chr11_-_99438143 | 1.06 |
ENSMUST00000017743.2
|
Krt20
|
keratin 20 |
chr2_+_129228022 | 1.06 |
ENSMUST00000148548.1
|
A730036I17Rik
|
RIKEN cDNA A730036I17 gene |
chr7_-_47528862 | 1.05 |
ENSMUST00000172559.1
|
Mrgpra2b
|
MAS-related GPR, member A2B |
chr11_+_32286946 | 1.05 |
ENSMUST00000101387.3
|
Hbq1b
|
hemoglobin, theta 1B |
chr2_-_164404606 | 1.05 |
ENSMUST00000109359.1
ENSMUST00000109358.1 ENSMUST00000103103.3 |
Matn4
|
matrilin 4 |
chr11_+_74619594 | 1.04 |
ENSMUST00000100866.2
|
E130309D14Rik
|
RIKEN cDNA E130309D14 gene |
chr12_-_115790884 | 1.03 |
ENSMUST00000081809.5
|
Ighv1-73
|
immunoglobulin heavy variable 1-73 |
chr15_-_79742518 | 1.03 |
ENSMUST00000089311.4
ENSMUST00000046259.7 |
Sun2
|
Sad1 and UNC84 domain containing 2 |
chr16_+_22951072 | 1.02 |
ENSMUST00000023590.8
|
Hrg
|
histidine-rich glycoprotein |
chr7_-_139978748 | 1.01 |
ENSMUST00000097970.2
|
6430531B16Rik
|
RIKEN cDNA 6430531B16 gene |
chr17_+_34238896 | 1.00 |
ENSMUST00000095342.3
|
H2-Ob
|
histocompatibility 2, O region beta locus |
chr11_-_103749815 | 0.99 |
ENSMUST00000018630.2
|
Wnt9b
|
wingless-type MMTV integration site 9B |
chr7_+_24370255 | 0.99 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr6_+_48860339 | 0.98 |
ENSMUST00000101425.3
|
Gm7932
|
predicted gene 7932 |
chr2_+_164948219 | 0.98 |
ENSMUST00000017881.2
|
Mmp9
|
matrix metallopeptidase 9 |
chr1_+_171370345 | 0.98 |
ENSMUST00000006578.3
ENSMUST00000094325.4 |
Pvrl4
|
poliovirus receptor-related 4 |
chr11_+_72999069 | 0.98 |
ENSMUST00000021141.7
|
P2rx1
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
chr7_-_25005895 | 0.98 |
ENSMUST00000102858.3
ENSMUST00000080882.6 |
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr2_+_163122605 | 0.98 |
ENSMUST00000144092.1
|
Gm11454
|
predicted gene 11454 |
chr16_-_16863975 | 0.97 |
ENSMUST00000100136.3
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr9_+_123150941 | 0.97 |
ENSMUST00000026890.4
|
Clec3b
|
C-type lectin domain family 3, member b |
chr11_+_83709015 | 0.96 |
ENSMUST00000001009.7
|
Wfdc18
|
WAP four-disulfide core domain 18 |
chr6_+_70726430 | 0.96 |
ENSMUST00000103410.1
|
Igkc
|
immunoglobulin kappa constant |
chr6_-_98342728 | 0.96 |
ENSMUST00000164491.1
|
Gm765
|
predicted gene 765 |
chr3_-_88548249 | 0.96 |
ENSMUST00000131775.1
ENSMUST00000008745.6 |
Rab25
|
RAB25, member RAS oncogene family |
chr17_-_84682932 | 0.95 |
ENSMUST00000066175.3
|
Abcg5
|
ATP-binding cassette, sub-family G (WHITE), member 5 |
chr19_-_10678001 | 0.95 |
ENSMUST00000025647.5
|
Pga5
|
pepsinogen 5, group I |
chr2_-_165400398 | 0.95 |
ENSMUST00000029213.4
|
Ocstamp
|
osteoclast stimulatory transmembrane protein |
chr2_-_163918683 | 0.95 |
ENSMUST00000044734.2
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr7_+_43408187 | 0.95 |
ENSMUST00000005592.6
|
Siglecg
|
sialic acid binding Ig-like lectin G |
chr15_-_74752963 | 0.94 |
ENSMUST00000023259.8
|
Lynx1
|
Ly6/neurotoxin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.4 | 4.1 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
1.2 | 3.6 | GO:1990535 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
1.2 | 3.5 | GO:0010949 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
1.1 | 3.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.8 | 11.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.8 | 3.9 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.8 | 2.3 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.7 | 4.2 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.7 | 2.0 | GO:0030221 | basophil differentiation(GO:0030221) |
0.7 | 2.0 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.6 | 1.9 | GO:0009753 | sesquiterpenoid metabolic process(GO:0006714) response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.6 | 1.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.6 | 1.8 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.6 | 1.8 | GO:0072098 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
0.6 | 1.7 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.6 | 2.3 | GO:0051586 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 4.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.5 | 2.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.5 | 1.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.5 | 3.6 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.5 | 1.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.5 | 7.8 | GO:0031000 | response to caffeine(GO:0031000) |
0.5 | 1.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.5 | 1.4 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.5 | 1.9 | GO:0002587 | negative regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002587) |
0.5 | 1.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.5 | 1.4 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.4 | 1.7 | GO:0045575 | basophil activation(GO:0045575) |
0.4 | 2.1 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.4 | 1.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 1.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 3.3 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.4 | 1.7 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.4 | 1.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 0.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.4 | 1.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.4 | 1.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.4 | 1.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 1.2 | GO:1902617 | response to fluoride(GO:1902617) |
0.4 | 1.8 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.4 | 0.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.4 | 1.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 2.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 0.4 | GO:1900239 | regulation of phenotypic switching(GO:1900239) |
0.3 | 2.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.3 | 1.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 0.7 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.3 | 1.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.3 | 9.1 | GO:0097435 | fibril organization(GO:0097435) |
0.3 | 0.9 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.3 | 1.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.3 | 0.9 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.3 | 0.9 | GO:1902867 | negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.3 | 0.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 0.9 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 1.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.3 | 0.9 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 0.6 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.3 | 0.6 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.3 | 1.1 | GO:0051885 | positive regulation of anagen(GO:0051885) |
0.3 | 0.8 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.3 | 3.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 1.1 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.3 | 1.1 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.3 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 0.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.3 | 0.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.3 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.5 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.3 | 1.1 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.3 | 0.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 5.9 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 1.3 | GO:0030421 | defecation(GO:0030421) |
0.3 | 32.3 | GO:0007586 | digestion(GO:0007586) |
0.2 | 0.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.7 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.7 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
0.2 | 1.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.2 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 1.0 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.2 | 1.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 7.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.9 | GO:0090346 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 1.2 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.2 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 1.4 | GO:0050955 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) thermoception(GO:0050955) |
0.2 | 1.6 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.2 | 0.7 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 1.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.2 | 0.2 | GO:0071726 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 1.5 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.2 | 0.6 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.2 | 2.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.6 | GO:0072708 | response to sorbitol(GO:0072708) response to dithiothreitol(GO:0072720) |
0.2 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.2 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.2 | 1.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.2 | 0.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 2.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 1.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 1.0 | GO:0072181 | mesonephric duct formation(GO:0072181) |
0.2 | 1.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.2 | 0.6 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.2 | 0.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.2 | 0.9 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.2 | 1.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.4 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 2.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 1.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 2.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 2.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 0.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 1.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 0.2 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.2 | 0.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 1.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 0.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.2 | 0.7 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 0.7 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.2 | 0.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.2 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 1.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.7 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 3.7 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.2 | 0.7 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.3 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 0.5 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.3 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.2 | 0.5 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.2 | 1.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.5 | GO:0002541 | plasma kallikrein-kinin cascade(GO:0002353) activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 1.7 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.5 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 0.6 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.2 | 0.3 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.2 | 1.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.2 | 0.5 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.1 | 0.9 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 1.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 3.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 0.6 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.9 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.7 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.1 | 0.6 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.1 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.8 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 1.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 1.2 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 1.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 1.6 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 0.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.8 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.1 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.4 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.1 | 0.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.9 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.5 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.4 | GO:1904209 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 1.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 1.4 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.5 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.4 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 1.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.4 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 0.5 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.1 | 1.3 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.1 | 0.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.4 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.1 | 2.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.2 | GO:2000229 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 1.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.8 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.1 | 1.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.8 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.1 | 0.8 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 3.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.7 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 3.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.5 | GO:1905165 | regulation of lysosomal protein catabolic process(GO:1905165) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 3.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0033374 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.1 | 1.1 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.9 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.2 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.1 | 1.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.3 | GO:0071846 | actin filament debranching(GO:0071846) |
0.1 | 0.4 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.2 | GO:0061035 | regulation of cartilage development(GO:0061035) |
0.1 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.3 | GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
0.1 | 0.1 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.2 | GO:1990764 | positive regulation of platelet aggregation(GO:1901731) regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.9 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.1 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.9 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.4 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 1.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 1.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.4 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.5 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.1 | GO:0003195 | tricuspid valve formation(GO:0003195) |
0.1 | 0.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.6 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.6 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.5 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.4 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:1902430 | neuronal signal transduction(GO:0023041) negative regulation of beta-amyloid formation(GO:1902430) |
0.1 | 0.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.1 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 1.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.4 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.3 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.1 | 0.5 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.2 | GO:1904020 | positive regulation of adenosine receptor signaling pathway(GO:0060168) regulation of G-protein coupled receptor internalization(GO:1904020) |
0.1 | 0.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.1 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.1 | 0.3 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.1 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.7 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 1.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.1 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.1 | 0.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.8 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 3.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.7 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 3.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.9 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 1.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.4 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.1 | 0.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.4 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.3 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.1 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 2.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.1 | 0.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.2 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 0.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 1.2 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.2 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 1.1 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.2 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.1 | 0.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 0.4 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.1 | 0.1 | GO:0002352 | B cell negative selection(GO:0002352) |
0.1 | 0.1 | GO:0071051 | U4 snRNA 3'-end processing(GO:0034475) polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 1.0 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.1 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.3 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.4 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.1 | 0.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 1.0 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.4 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.6 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.1 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.1 | 0.6 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.2 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0032747 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.4 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.6 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.5 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.1 | 0.2 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.1 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.2 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.1 | 0.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.3 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 1.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.4 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 1.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.8 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.2 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.5 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 1.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 1.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 1.5 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 4.3 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 1.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.1 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.7 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.6 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.1 | GO:0032847 | positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.1 | 0.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.7 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 | 0.2 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.5 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.3 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.1 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.1 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.1 | 0.3 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.3 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.1 | GO:2000566 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.1 | 0.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 1.5 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.2 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.5 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.1 | 0.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.0 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.0 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.2 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.0 | 0.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 1.7 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 1.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.2 | GO:0046952 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.0 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.2 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.1 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
0.0 | 0.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
0.0 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 1.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 1.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.2 | GO:1902564 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 3.0 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0006788 | heme oxidation(GO:0006788) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.3 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.1 | GO:2000341 | ERK5 cascade(GO:0070375) chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.0 | 0.2 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.0 | 0.2 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.0 | 0.7 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.0 | 0.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.3 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
0.0 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 1.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.0 | 1.8 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.0 | 0.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.0 | 0.3 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.2 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
0.0 | 0.3 | GO:0051198 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 1.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 2.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 0.8 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.4 | GO:0071467 | cellular response to pH(GO:0071467) |
0.0 | 0.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.4 | GO:0007440 | foregut morphogenesis(GO:0007440) |
0.0 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 3.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 0.2 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.0 | 0.2 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.0 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.2 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.1 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
0.0 | 0.3 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.0 | 0.2 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.1 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.0 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |